Zetta Genomics specializes in genomic data management through its innovative platform, XetaBase, which is designed to enhance the application of genomic data across various sectors, including clinical diagnostics, healthcare initiatives, biopharmaceuticals, and research institutions. XetaBase is a genomic-native technology that optimizes data management, enabling efficient handling of large and complex genomic datasets. It provides a comprehensive solution for loading, normalizing, aggregating, indexing, annotating, filtering, visualizing, and enriching genomic data, facilitating real-time analysis and insights. The platform's scalability allows it to manage hundreds of thousands of genomes and trillions of variants, making it a powerful tool for both research and clinical applications.

The technology behind XetaBase empowers users to streamline precision medicine, enhance clinical diagnostics, and accelerate research discoveries. It integrates seamlessly with electronic health records (EHRs) and laboratory information management systems (LIMS), ensuring smooth connectivity between clinical and genomic data. Additionally, XetaBase supports advanced analytics and visualization capabilities, allowing researchers and clinicians to derive actionable insights from complex datasets. By fostering collaboration among bioinformaticians, clinicians, and geneticists, Zetta Genomics aims to drive advancements in precision medicine and improve health outcomes on a global scale.

United Kingdom

Zetta provides large-scale genomic data management using distributed database technology and best practice security techniques to leverage genomicdata benefits while preserving data privacy.

Zetta Genomics

Company Details